Delivery Order SPE2DB22D3501-SPE2DB26FTL55
- Not listed
- The Defense Logistics Agency awarded a $2,132.69 delivery order to AmerisourceBergen Drug Corp for Phytonadione 1 mg/0.5 mL syringes on June 13, 2025, with an ultimate completion date of June 16, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. Phytonadione, commonly known as Vitamin K1, is a critical pharmaceutical used to treat vitamin K...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Phytonadione 1 mg/0.5 mL syringes valued at $2,716.90, with completion targeted for July 21, 2025. This is a firm fixed-price contract with no set-aside designation, meaning it was awarded through open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued...
- The Defense Logistics Agency awarded a $21,587.42 firm fixed-price delivery order to AmerisourceBergen Drug Corp for phytonadione 1 mg/0.5 mL syringes with an ultimate completion date of September 9, 2025. Phytonadione, commonly known as vitamin K1, is a critical pharmaceutical used for blood clotting disorders and vitamin K deficiency treatment. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply...
- The Defense Logistics Agency (DLA) awarded a $1,452.64 delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Phytonadione 10 mg/ml ampules. This is a firm fixed price contract with no set-aside designation, classified as a child contract under a larger vehicle. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of August 27, 2025. Phytonadione, commonly known as Vitamin K1, is a critical...
- The Defense Logistics Agency awarded a delivery order valued at $10,492.26 to AmerisourceBergen Drug Corp for the supply of Phytonadione 1 mg/0.5 mL syringes in 0.5 mL units. This contract, issued on August 22, 2025, with an ultimate completion date of August 25, 2025, represents a firm fixed-price delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. Phytonadione, commonly known as vitamin K1,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Phytonadione 1 mg/0.5 mL syringes in 0.5 mL quantities. This firm fixed-price delivery order, valued at $4,843.91, represents a non-competitive set-aside and is scheduled for completion by October 23, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Phytonadione, also known as vitamin K1, is a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Phytonadione 1 mg/0.5 mL syringes in 0.5 mL units, valued at $3,037.93. This is a firm fixed price delivery order with no set-aside designation, utilizing competitive procurement procedures. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 22, 2025. Phytonadione, commonly...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 3, 2025, for Phytonadione 1 mg/0.5 mL syringes with a contract ceiling value of $6,851.88. This is a firm fixed price delivery order with an ultimate completion date of June 4, 2025, and represents a non-set-aside competitive award. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Phytonadione, commonly known as Vitamin K1, is a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Phytonadione 1 mg/0.5 mL syringes with a ceiling value of $20,559.12. This firm fixed-price delivery order, with an ultimate completion date of July 25, 2025, represents a competitively awarded contract with no set-aside designation. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $2,454.71 on September 10, 2025, for the supply of Phytonadione 1 mg/0.5 mL syringes in 0.5 mL quantities. This firm fixed price, competitively awarded contract is a child order under the company's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The order will be performed at the contractor's corporate office...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB26FTL55Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,637.73 to AmerisourceBergen Drug Corp for the supply of Phytonadione 1 mg/0.5 mL syringes in 0.5 mL units. This is a firm fixed-price, competitively awarded contract with no set-aside designation, set to be completed by November 12, 2025. The order will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. Phytonadione, commonly known as Vitamin K1, is a critical pharmaceutical used in medical settings for blood coagulation management and is essential for military and federal healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999 million and extends through December 2026. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp serves as a prime vendor supplying a comprehensive range of generic and brand-name medications, vaccines, and medical supplies to support military healthcare programs globally. The company's significant contract portfolio with DLA demonstrates its capability to meet federal procurement requirements for critical pharmaceutical commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.6k | 11/10/25 |